Contemporary Disengagement From Antiretroviral Therapy in the Western Cape, South Africa: A Cross-Sectional Study. [PDF]
Euvrard J +8 more
europepmc +1 more source
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source
Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control. [PDF]
Bolluyt DC, de Bree GJ, Pasternak AO.
europepmc +1 more source
ABSTRACT Introduction Multi‐month dispensing (MMD), as a differentiated service delivery model, can reduce the frequency of clinic visits, waiting time and travel costs for clinically stable people living with HIV. This study aimed to evaluate the impact of 6‐month MMD of antiretroviral therapy (ART) on retention and conduct a cost analysis in China ...
Wenqi Shang +8 more
wiley +1 more source
Cause-specific hazards of antiretroviral therapy programmatic adherence, defaulting and mortality among HIV/AIDS patients who had attained CD4 count recovery after antiretroviral therapy initiation in South Africa. [PDF]
Mashiri CE +3 more
europepmc +1 more source
ABSTRACT The Kaposi Sarcoma herpesvirus (KSHV) causes Kaposi sarcoma (KS), primary effusion lymphoma, a lymphoproliferative disease (KSHV‐multicentric Castleman's disease), and a cytokine inflammatory syndrome (KICS). These diseases occur more frequently, though not exclusively, among people living with HIV or other types of immune dysregulation. While
Julian Naipauer +10 more
wiley +1 more source
Predictors of Weight Gain in Individuals Living with HIV on Antiretroviral Therapy: A Cross-Sectional Study. [PDF]
Medeiros THRES +14 more
europepmc +1 more source
sVCAM‐1 and Hematological Profiles Are Associated With CD4‐Defined Disease Status in HIV Infection
ABSTRACT Brazil stands out for its progressive public health policies against HIV, including universal access to antiretroviral therapy and a stricter AIDS definition (CD4 < 350 cells/mm3) compared to the World Health Organization (WHO) criterion (CD4 ≤ 200 cells/mm3).
Bruno Almeida‐Silva +8 more
wiley +1 more source
Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV.
Figueroa JF +6 more
europepmc +1 more source
Quantifying the impact of health service delivery barriers on access to healthcare: a case study of antiretroviral therapy in Mali. [PDF]
Timoner P +7 more
europepmc +1 more source

